FDA Drug · D-0609-2026

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Class II · Ongoing

Subpotent Drug

Advertisement
Advertisement
Affected lots / codes — check yours against thisLots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
Recalling firm
The Harvard Drug Group LLC, Dublin, OH
Classification
Class II (temporary or reversible harm possible)
Status
Ongoing
Quantity
790 Cartons.
Distribution
U.S. Nationwide.
Recall initiated
June 16, 2026
Classified
June 22, 2026
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0609-2026%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →